PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus erythematosus, systemic |
| Phenotype | C0020538|hypertension |
| Sentences | 26 |
| PubMedID- 21376432 | [pulmonary arterial hypertension in systemic lupus erythematosus]. |
| PubMedID- 26084696 | An impaired neuroimmune pathway promotes the development of hypertension in systemic lupus erythematosus. |
| PubMedID- 22489252 | Tables 2 and 3 summarize the pathology and the key causative mechanisms in pulmonary arterial hypertension due to systemic lupus erythematosus [40–64]. |
| PubMedID- 25929760 | Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study. |
| PubMedID- 22983159 | Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in chinese population. |
| PubMedID- 24562636 | Disease activity is related to acute response to vasodilator in pulmonary artery hypertension associated with systemic lupus erythematosus. |
| PubMedID- 26087631 | Aim: to study the specific features of the development and course of hypertension in patients with systemic lupus erythematosus (sle). |
| PubMedID- 24263143 | Pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause. |
| PubMedID- 21170884 | Liddle syndrome, a rare cause of hypertension, is now known to be caused by a mutation in tubular transport, due to a mutation in the scnn1b gene, encoding for a na+ channel protein (enac). |
| PubMedID- 23752887 | Renal vascular hypertension in patients with alagille syndrome is explained by the widespread vasculopathy and the role of notch signalling in vascular development. |
| PubMedID- 24238697 | Pulmonary hypertension in systemic lupus erythematosus. |
| PubMedID- 23560122 | There were also other conditions such as small kidney, tuberculosis infection, urinary tract obstruction, history of schistosomiasis infection, systemic lupus erythematosus (sle) with hypertension, malaria infection, malignancy with hypertension and traditional african herbal poisoning which were found in the patients. |
| PubMedID- 22841984 | Objectives: to investigate the prevalence and predictors of pulmonary hypertension (ph) in patients with systemic lupus erythematosus (sle) and to validate a diagnostic strategy. |
| PubMedID- 22084605 | Asymptomatic pulmonary hypertension in systemic lupus erythematosus. |
| PubMedID- 20012052 | Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. |
| PubMedID- 23104392 | Intracranial hypertension associated with systemic lupus erythematosus in a young male patient. |
| PubMedID- 22300830 | Objective: to evaluate the occurrence of idiopathic intracranial hypertension (iih) in patients with systemic lupus erythematosus (sle) and to describe the manifestations, treatments and outcomes in these patients. |
| PubMedID- 24134304 | Objectives: to determine whether disease activity verified by laboratorial parameters is associated with a higher frequency of hypertension in patients with systemic lupus erythematosus (sle) without renal impairment and to investigate factors that could influence this hypertension. |
| PubMedID- 22525199 | A literature review identified several anecdotal reports of alagille syndrome associated with hypertension, renal artery stenosis and/or midaortic syndrome. |
| PubMedID- 21597395 | Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia. |
| PubMedID- 25750566 | Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. |
| PubMedID- 26401258 | All patients with pulmonary hypertension and a diagnosis of systemic sclerosis, systemic lupus erythematosus, or mixed connective tissue disease who underwent the 6mwt between august 1, 2009, and october 30, 2011, were included (n = 66). |
| PubMedID- 24755203 | Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus. |
| PubMedID- 24633036 | Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus. |
| PubMedID- 23634923 | Results: the patients' median age was 43 years (range 30-55 years) and the ich etiology was hypertension in 4 of 5 patients, and systemic lupus erythematosus vasculitis in 1 patient. |
| PubMedID- 24599923 | Pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survival. |
Page: 1